GlassScriptPhysician profile
Brian Thomas Engel
NPI 1942387410
$1,410.96
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $218 · 2021: $269 · 2022: $256 · 2023: $203 · 2024: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $264.40 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Tris Pharma INC | $179.97 | 2019-2024 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $161.78 | 2019-2024 | Rotarix, Bexsero |
| Pfizer INC. | $104.98 | 2019-2024 | |
| Sanofi Pasteur INC. | $104.91 | 2019-2023 | |
| Cranial Technologies, INC | $100.82 | 2019-2024 | Doc Band |
| Kaleo, INC. | $82.34 | 2019-2023 | Auvi-Q |
| Adlon Therapeutics L.P. | $80.60 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.83 | 2019-2022 | |
| Biomarin Pharmaceutical INC. | $60.31 | 2021-2024 | Voxzogo 1.2mg |
| Ironshore Pharmaceuticals INC. | $41.00 | 2019 | |
| Corium, LLC | $34.02 | 2022-2023 | Azstarys |
| Verrica Pharmaceuticals INC. | $21.29 | 2024 | Ycanth |
| Sobi, INC | $19.13 | 2023 | |
| Cognoa, INC. | $17.35 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $16.22 | 2023 | Qelbree |
| Phadia US INC. | $16.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.97 | 2024 | Flumist Quadrivalent |
| Alexion Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Engel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.